721 followers
#HealthEconJA Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm… https://t.co/gkYZfMZ1u7
#HealthEconJA Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm… https://t.co/gkYZfMZ1u7